ATE261736T1 - Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen - Google Patents

Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen

Info

Publication number
ATE261736T1
ATE261736T1 AT98903356T AT98903356T ATE261736T1 AT E261736 T1 ATE261736 T1 AT E261736T1 AT 98903356 T AT98903356 T AT 98903356T AT 98903356 T AT98903356 T AT 98903356T AT E261736 T1 ATE261736 T1 AT E261736T1
Authority
AT
Austria
Prior art keywords
lyophilizate
water
lipid complex
porphyrins
insoluble
Prior art date
Application number
AT98903356T
Other languages
English (en)
Inventor
Mathew Cherian
Shireesh Prakash Apte
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE261736T1 publication Critical patent/ATE261736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98903356T 1997-01-28 1998-01-28 Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen ATE261736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78956697A 1997-01-28 1997-01-28
PCT/US1998/000033 WO1998032463A2 (en) 1997-01-28 1998-01-28 Lyophilizate of lipid complex of water insoluble porphyrins

Publications (1)

Publication Number Publication Date
ATE261736T1 true ATE261736T1 (de) 2004-04-15

Family

ID=25148009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903356T ATE261736T1 (de) 1997-01-28 1998-01-28 Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen

Country Status (9)

Country Link
EP (1) EP1030686B1 (de)
JP (1) JP2001511128A (de)
AT (1) ATE261736T1 (de)
AU (1) AU6015298A (de)
DE (1) DE69822496T2 (de)
DK (1) DK1030686T3 (de)
ES (1) ES2218805T3 (de)
PT (1) PT1030686E (de)
WO (1) WO1998032463A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP4669837B2 (ja) * 2004-03-04 2011-04-13 真 湯浅 金属ポルフィリン錯体包埋ニオソーム、その製造法およびこれを利用する医薬
JP4591820B2 (ja) * 2005-01-31 2010-12-01 株式会社ケムコ 化学発光試薬
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2007140416A2 (en) 2006-05-30 2007-12-06 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP3735944A1 (de) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP6190534B2 (ja) 2013-08-22 2017-08-30 ソニー株式会社 水溶性蛍光染料又は有色染料及びその使用方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko) 2015-06-03 2024-03-22 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
AU2017240154B2 (en) 2016-04-01 2021-08-12 Sony Group Corporation Ultra bright dimeric or polymeric dyes
EP3440136B1 (de) 2016-04-06 2025-07-23 Sony Group Corporation Ultrahelle dimere oder polymere farbstoffe mit abstandslinkergruppen
US11685835B2 (en) 2016-05-11 2023-06-27 Sony Corporation Ultra bright dimeric or polymeric dyes
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7312929B2 (ja) 2016-07-29 2023-07-24 ソニーグループ株式会社 超明色二量体またはポリマー色素およびその調製のための方法
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
CN111315415A (zh) 2017-10-05 2020-06-19 索尼公司 可编程的聚合药物
EP3691689A1 (de) * 2017-10-05 2020-08-12 Sony Corporation Programmierbare dendritische arzneimittel
WO2019099789A1 (en) 2017-11-16 2019-05-23 Sony Corporation Programmable polymeric drugs
EP3737419B1 (de) 2018-01-12 2024-04-10 Sony Group Corporation Phosphoalkylpolymere mit biologisch aktiven verbindungen
JP2021510698A (ja) 2018-01-12 2021-04-30 ソニー株式会社 生物学的に活性な化合物を含むホスホアルキルリボースポリマー
JP7813098B2 (ja) 2018-01-12 2026-02-12 ソニーグループ株式会社 生物学的に活性な化合物を含む剛性間隔基を有するポリマー
CN112041680A (zh) 2018-03-19 2020-12-04 索尼公司 二价金属用于增强荧光信号的应用
EP3768689A1 (de) 2018-03-21 2021-01-27 Sony Corporation Polymere tandemfarbstoffe mit linkergruppen
CN112313242A (zh) 2018-06-27 2021-02-02 索尼公司 具有含脱氧核糖的连接体基团的聚合物染料
KR20210032434A (ko) 2018-07-13 2021-03-24 소니 주식회사 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료
CN113383043A (zh) 2019-09-26 2021-09-10 索尼集团公司 具有连接体基团的聚合物串联染料
JP2023552448A (ja) 2020-12-07 2023-12-15 ソニーグループ株式会社 二量体色素又はポリマー色素における輝度を増強するためのスペーシングリンカー基の設計

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer

Also Published As

Publication number Publication date
EP1030686A2 (de) 2000-08-30
ES2218805T3 (es) 2004-11-16
DK1030686T3 (da) 2004-04-13
PT1030686E (pt) 2004-06-30
DE69822496T2 (de) 2005-03-03
EP1030686B1 (de) 2004-03-17
AU6015298A (en) 1998-08-18
DE69822496D1 (de) 2004-04-22
JP2001511128A (ja) 2001-08-07
WO1998032463A3 (en) 1998-10-22
WO1998032463A2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
ATE261736T1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
AU2709495A (en) Sphingosomes for enhanced drug delivery
DE69310014D1 (de) Liposomen mit Porphyrin-Photosensibilisatoren enthaltende Mittel
ZA951292B (en) 4-amino derivatives of mycophenolic acid
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
MY130110A (en) 6-substituted mycophenolic acid and derivatives
ATE259650T1 (de) Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen
ES2153665T3 (es) Usos terapeuticos de productos proteicos bactericidas/incrementadores de la permeabilidad (bpi) para la meningococemia humana.
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
DE59005281D1 (de) Pharmazeutische präparate.
MX9101448A (es) Agentes quimioterapeuticos y metodo para hacerlos
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
LV12149A (lv) 5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
MX9708111A (es) Lipidos cationicos para terapia genica.
UA29648A (uk) Спосіб лікування хімічних опіків стравоходу
UA7951A (uk) Спосіб сочетаної вакуум-лазерної терапії

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1030686

Country of ref document: EP

REN Ceased due to non-payment of the annual fee